The three somatostatin analogues significantly inhibited GH release in GC tumor cultures (Fig. 5B), with BIM-23120 showing the highest inhibitory effect (34.3%) followed by octreotide (28.3%) and SOM-230 (19%). The gene discussed is GRHL3; the disease is neoplasm.